Skip to main content

Table 1 Comparison between patients with MACE and patients without MACE regarding clinical and laboratory data and Grace risk assessment score on admission

From: Short-term prognostic value of TAPSE, RVFAC and Tricuspid S’ wave peak systolic velocity after first acute myocardial infarction

 

Patients with MACE [n = 106, (39.8%)]

Patients without MACE [n = 160, (60.2%)]

P value*

Mean (SD)

Mean (SD)

Age (years)

61.36 (6.941)

61.08 (8.60)

0.78

Heart rate (Bpm)

85.98 (21.43)

88.44 (18.09)

0.32

Systolic blood pressure (mmHg)

127.36 (26.69)

129.438 (23.54)

0.51

Serum creatinine (mg/dl)

1.19 (0.38)

1.24 (0.43)

0.32

Random blood sugar (mg/dl)

203.09 (90.38)

200.43 (85.50)

0.81

Hemoglobin (gm/dl)

12.06 (1.40)

12.13 (1.41)

0.71

Grace score

135.38 (37.49)

126.14 (33.20)

0.036*

  1. Patients with MACE: Patients who died or have experienced events in whole 30-days period post AMI; Patients without MACE: Patients who survived and have not experience events in whole 30-days period post AMI
  2. * p value < 0.05
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us